To include your compound in the COVID-19 Resource Center, submit it here.

ASCO by the numbers

ASCO by the numbers

Top indications Breast and lung cancer dominate the presentations at this year's American Society of Clinical Oncology (ASCO) meeting, which kicked off on Friday in Chicago. About one-fifth of the 404 breast cancer abstracts cover triple-negative breast cancer (TNBC), one of the most challenging subsets of the disease. In contrast, only 8% of the 401 lung cancer abstracts described work in the poorly served small cell lung cancer (SCLC)

Read the full 722 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers